Vertex Pharmaceuticals Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VRTX Nasdaq 2836 www.vrtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vertex Pharmaceuticals Incorporated

Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? - Jun 8th, 2026 12:54 pm
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors - Jun 8th, 2026 1:00 am
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains - Jun 6th, 2026 2:06 am
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference - Jun 5th, 2026 10:00 am
Acadia (ACAD) Down 3.7% Since Last Earnings Report: Can It Rebound? - Jun 5th, 2026 9:30 am
Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report? - Jun 4th, 2026 9:30 am
The Best Stocks to Invest $500 in Right Now - Jun 4th, 2026 1:05 am
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10 - Jun 3rd, 2026 2:00 pm
Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue? - Jun 3rd, 2026 9:30 am
Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation? - Jun 2nd, 2026 3:16 pm
Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative? - Jun 2nd, 2026 10:09 am
Got $5,000? 1 Cash-Flow King to Buy and Hold Forever That Wall Street Is Completely Mispricing - Jun 2nd, 2026 10:02 am
FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy - Jun 2nd, 2026 9:09 am
Vertex Pharmaceuticals Stock: Is VRTX Underperforming the Healthcare Sector? - Jun 1st, 2026 12:03 pm
Vertex Stock Down Nearly 8% in 3 Months: Time to Buy or Stay Cautious? - Jun 1st, 2026 7:24 am
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Jun 1st, 2026 7:00 am
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy - Jun 1st, 2026 6:00 am
Is Regeneron Pharmaceuticals Stock Underperforming the Dow? - Jun 1st, 2026 4:42 am
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026? - May 31st, 2026 10:31 am
2 Healthcare Stocks with Exciting Potential and 1 Facing Challenges - May 29th, 2026 5:44 am